New cancer clinical trial: [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)

Published on: October 30, 2018 at 12:00PM
Conditions:   Breast Cancer;   Prostate Cancer;   Colorectal Cancer;   Non Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention:   Drug: [68Ga]-NeoBOMB1
Sponsor:   Advanced Accelerator Applications
Recruiting
https://ift.tt/2Q4PTsB